van Ommen-Nijhof A, Steenbruggen TG, Wiersma TG, Balduzzi S, et al. Intensified alkylating chemotherapy for patients with oligometastatic breast cancer harboring homologous recombination deficiency: Primary outcomes from the randomized phase III OLIGO study. Eur J Cancer 2024;213:115083.
PMID: 39489924